Assessment of the quality of life of patients with advanced and end- stage cancer or serious infections with a symptom-based or an impact-based instrument

Supportive Care in Cancer

Volumn 7, Issue 2, 1999, Pages 64-70

  Witteveen, P O ^a   Jacobs, H M ^b   Van Groenestijn, M A C ^a   Lodder, A C ^b   Van Boxtel, A H ^a   Nieuwland, M ^a   Post, M W M ^b   Touw Otten, F W M M ^b   Blijham, G H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Palliative care; Quality of life; Sickness Impact Profile

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; FACTORIAL ANALYSIS; FEMALE; HEALTH STATUS; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; TERMINAL CARE;

ACTIVITIES OF DAILY LIVING; ADULT; ATTITUDE TO HEALTH; FEMALE; FLUID THERAPY; HEALTH STATUS; HIV INFECTIONS; HOME CARE SERVICES; HOME INFUSION THERAPY; HUMANS; INFUSIONS, PARENTERAL; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE;

EID: 0032997906     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050228     Document Type: Article

References (31)

1. Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden PO, Haglund U, Svensson C, Enander LK, Linne T, Sellstrom H, Heuman R (1997) Randomized comparison between chemotherapy plus best supportive care with supportive care in advanced gastric cancer. Ann Oncol 8:163-168
2. O'Shaughnessy JA, Wittes RE Burke G (1991) Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. J Clin Oncol 9:2225-2232
3. Burris HA, Moore MJ, Andersen JS, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Stornioli AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403-2413
4. Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA, Green MR, Tarassoff P, Brown TD, Casper ES, Stornioli AM, Von Hoff DD (1996) A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 7:347-353
5. De Haes JCM, Olschewski M, Fayers P, et al (1996) Measuring the quality of life of cancer patients with the Rotterdam Symptom Checklist (RSCL), a manual. Northern Centre for Health Care Research, Groningen
6. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, De Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
7. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomy A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K, Lloyd S, Purl S, Blendowski C, Goodman M, Barbicle M, Stewart I, McHale M, Bonomi P, Kaplan E, Taylor S IV, Thomas CR, Hams J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570-579
8. Bergner M, Bobbitt RA, Carter WB Gilson BS (1981) The sickness impact profile: development and final revision of a health status measure. Med Care 19:787-805
9. Schipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the quality of life of cancer patients: the functional living index cancer: development and validation. J Clin Oncol 2:472-483
10. Witteveen PO, Van Boxtel AH, Nieuwland M, Neijt JP Blijham GH (1995) Feasibility of moving the medical technology for patients with cancer or serious infectious diseases to the home setting (in Dutch with English summary). Ned Tijdschr Geneeskd 139:788-791
11. Carter WB, Bobbitt RA, Bergner M Gilson BS (1976) Validation and interval scaling: the sickness impact profile. Health Serv Res 516-527
12. Bergner M, Bobbitt RA, Kressel S, Pollard WE, Gilson BS, Morris JR (1976) The sickness impact profile: conceptual formulation and methodology for the development of a health status measure. Int J Health Serv 6:393-414
13. Jacobs HM, Luttik A, Touw-Otten FWMM, De Melker RA (1990) The sickness impact profile: results of a validation study of the Dutch version (in Dutch with English summary). Ned Tijdschr Geneeskd 134:1950-1954
14. Jacobs HM Touw-Otten FWMM (1995) The Dutch version of the sickness impact profile studied in a patient population of general practitioners (in Dutch). Huisarts en Wetenschap 38:122-128
15. De Haes JCJM, Van Knippenberg FCE, Neijt JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62:1034-1038
16. Richards MA, Hopwood P, Ramirez AJ, Twelves CJ, Ferguson J, Gregory WM, Swindell R, Scrivener W, Miller J, Howell A, Rubens RD (1992) Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life. Eur J Cancer [A] 28:1023-1028
17. Dobbs NA, Twelves CJ, Ramirez AJ, Towlson KE, Gregory WM, Richards MA (1993) Patient acceptability and practical implications of pharmacokinetic studies in patients with advanced cancer. Eur J Cancer [A] 29:1707-1711
18. Allen-Mersch TG, Earlam S, Fordy C, Abrams K, Houghton J (1994) Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasis. Lancet 344:1255-1260
19. Hopwood P, Howell, A Maguire P (1991) Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer 64:353-356
20. Greer S, Moorey S, Baruch JDR, Watson M, Robertson BM, Mason A, Rowden L, Law MG, Bliss JM (1992) Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. BMJ 304:675-680
21. Coscarelli Schag C, Heinrich RL, Ganz PA (1984) Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 2:187-193
22. Toothakker LE (1993) multiple comparison procedures. Sage, Newburry Park
23. Wallston KA, Burger C, Smith RA Baugher RJ (1988) Comparing the quality of death for hospice and non-hospice cancer patients. Med Care 26:177-182
24. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR (1981) Measuring the quality of life of cancer patients. J Chron Dis 34:585-597
25. Morris JR, Suissa S, Sherwood S, Wright SM Greer D (1986) Last days: a study of quality of life of terminally ill cancer patients. J Chron Dis 39:47-62
26. Buroker TR, O'Conell MJ, Wieand HS, Krook JE, Gerstner JB, Mailliard JA, Schaefer PL, Levitt R, Kardinal CG, Gesme DH Jr (1994) Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 12:14-20
27. Cole BF, Gelber RD Kirkwood JM (1996) A quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment for melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol 14:2777-2673
28. Ibbotson T, Maguire P, Selby PJ, Priestman T, Wallace L (1994) Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer [A] 30:37-40
29. Watson M, Law M, Maguire GP, Robertson B, Greer S, Bliss JM Ibbotson T (1992) Further development of a quality of life measure for cancer patients: the Rotterdam Symptom Checklist (revised). Psychooncology 1:35-44
30. Jacobs HM, Luttik A, Touw-Otten FWMM, Kastein M, Melker RA de (1992) Measuring impact of sickness in patients with nonspecific abdominal complaints in a Dutch family practice setting. Med Care 30:244-251
31. Visser MC, Fletcher AE, Parr G, Simpson, A Bulpitt CJ (1994) A comparison of three quality of life instruments in subjects with angina pectoris: the Sickness Impact Profile, the Nottingham Health Profile, and the Quality of Wellbeing Scale. J Clin Epidemiol 47:157-163